Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth

First Page		Document Content
Date: 2014-04-28 02:52:10 Complement system Nanomedicine Alternative complement pathway Nanotoxicology Anaphylatoxin Nanoparticle C3a Classical complement pathway Chemistry Biology		Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth Add to Reading List Source URL: pharmacy.ku.dk Download Document from Source Website File Size: 1,32 MB Share Document on Facebook

	8th International Congress of Nanotoxicology, Boston June 1-4, 2016 FIRST ANNOUNCEMENT WORKSHOP: “Assessing the dose of nanomaterials in toxicological studies: DocID: 1voPZ - View Document
	INTERNATIONAL NANOTOXICOLOGY CONGRESS nano DocID: 1v60X - View Document
	L NT NanoToxicology neg Text DocID: 1uDlq - View Document
	Post-doctoral fellow position #2 – Research Focus Nanotechnology/nanotoxicology - Safety of engineered nanomaterials The Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryl DocID: 1sM2j - View Document
	SENN2015 International Congress on Safety of Engineered Nanoparticles and NanotechnologiesApril 2015 Marina Congress Center, Helsinki, Finland Programme and Abstracts DocID: 1rd6F - View Document